Koshy Cherian, Ajeesh <br/><br/>
A systemically-available kynurenine aminotransferase II (KAT II) inhibitor restores nicotine-evoked glutamatergic activity in the cortex of rats.  [electronic resource] 

 -  Neuropharmacology  Jul 2014 
 - 41-8 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1873-7064 
<br/><br/><label>Standard No.: </label>10.1016/j.neuropharm.2014.03.004  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Central Nervous System Agents--pharmacology<br/>Enzyme Inhibitors--pharmacology<br/>Glutamic Acid--metabolism<br/>Kynurenic Acid--metabolism<br/>Kynurenine--pharmacology<br/>Male<br/>Membrane Potentials--drug effects<br/>Microdialysis<br/>Microelectrodes<br/>Nicotine--pharmacology<br/>Nicotinic Agonists--pharmacology<br/>Potassium Chloride--pharmacology<br/>Prefrontal Cortex--drug effects<br/>Pyrazoles--pharmacology<br/>Rats, Sprague-Dawley<br/>Rats, Wistar<br/>Transaminases--antagonists & inhibitors